Physician profile
Smitha Mantha
NPI 1689808479
$1,370.21
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.18 · 2021: $295 · 2022: $469 · 2023: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $281.76 | 2020-2023 | Augment Injectable |
| Davol INC. | $239.12 | 2022 | |
| Organogenesis INC. | $157.99 | 2021-2022 | |
| Corium, LLC | $121.82 | 2023 | Adlarity |
| Bioventus LLC | $120.13 | 2021 | |
| Trilliant Surgical LLC. | $101.69 | 2023 | Minimally Invasive Bunion Plate, Left |
| Vaporox, INC. | $77.73 | 2023 | Vht-200 Wound Treatment System |
| Pacira Pharmaceuticals Incorporated | $71.58 | 2021 | |
| Abbott Laboratories | $61.18 | 2023 | Proclaim, Eterna, Prodigy |
| Treace Medical Concepts, INC. | $51.26 | 2023 | |
| Nevro Corp. | $25.95 | 2022 | |
| Novastep INC. | $19.11 | 2022 | |
| Allergan, INC. | $16.23 | 2020 | |
| Depuy Synthes Sales INC. | $13.68 | 2021 | |
| Assertio Therapeutics, INC. | $10.98 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smitha Mantha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.